Nitrofurazone washing fluid, preparation method and application thereof

A nitrofuracil and flushing liquid technology, applied in the field of medicine, can solve the problems of lack of lubricity, neurological symptoms such as auditory hallucinations, visual hallucinations, hallucinations, dizziness, insomnia, multiple peripheral neuritis, allergic reactions and the like

Inactive Publication Date: 2011-10-12
85 HOSPITAL OF PEOPLES LIBERATION ARMY
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] 1. Those who are allergic to furan drugs should not use it
[0021] 2. Allergic reactions after oral administration, such as shock, asthma, shortness of breath, rash, etc.; gastrointestinal reactions, drug fever, eosinophilia and neurological symptoms such as auditory hallucinations, visual hallucinations, hallucinations, dizziness, insomnia and multiple seizures Peripheral neuritis, etc.
[0113] Its disadvantage is that the fibers washed with it feel bad
Disadvantages of lead salt stabilizers: poor dispersibility, high toxicity, initial coloring, difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitrofurazone washing fluid, preparation method and application thereof
  • Nitrofurazone washing fluid, preparation method and application thereof
  • Nitrofurazone washing fluid, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0563] Example 1,

[0564] Nitrofurazone 0.2g, Solutol HS 15 1g, sodium chloride 900g, adjust pH to 5.0, and dilute to 1000 mL with water for injection.

[0565] Preparation method: Take nitrofurazone, Solutol HS 15, sodium chloride, heat an appropriate amount of water for injection to dissolve, adjust the pH to 5.0, add 1g of activated carbon for injection, heat and boil for 30 minutes, stir, decarburize and filter until clear, add injection Make 1000ml with water, potting, and sterilizing at 115°C for 30 minutes.

Example Embodiment

[0566] Example 2,

[0567] Nitrofurazone 0.2g, Solutol HS 15 10g, sodium chloride 900g, adjusted to pH 5.0, dilute to 1000 mL with water for injection.

[0568] Preparation method: Take nitrofurazone, Solutol HS 15, sodium chloride, heat an appropriate amount of water for injection to dissolve, adjust the pH to 5.0, add 1g of activated carbon for injection, heat and boil for 30 minutes, stir, decarburize and filter until clear, add injection Make 1000ml with water, potting, and sterilizing at 115°C for 30 minutes.

Example Embodiment

[0569] Example 3.

[0570] Nitrofurazone 0.2g, Solutol HS 15 100g, sodium chloride 900g, adjust the pH to 5.0, and dilute to 1000 mL with water for injection.

[0571] Preparation method: Take nitrofurazone, Solutol HS 15, sodium chloride, heat an appropriate amount of water for injection to dissolve, adjust the pH to 5.0, add 1g of activated carbon for injection, heat and boil for 30 minutes, stir, decarburize and filter until clear, add injection Make 1000ml with water, potting, and sterilizing at 115°C for 30 minutes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel nitrofurazone washing fluid, which mainly comprises an active component nitrofurazone, a solubilizing agent polyethyleneglycol 15-hydroxyl stearate and a solvent injection water. Furthermore, one or more of cosolvent, pH regulator, osmotic pressure regulator and stabilizing agent can be added into the washing fluid. In the washing fluid, a novel solubilizer Solutol HS 15 has low haemolysis, extremely low histamine liberation and higher physiological tolerance, so that safety of clinical administration and compliance of patients are remarkably improved; the washing fluid has excellent stability and longer validity, and higher administration convenience is given to clinical doctors; and the washing fluid has better storage and transportation stability, higher clinical administration safety and patient compliance. The washing fluid has a simple preparation process, convenience in quality control, lower production cost and industrial production.

Description

technical field [0001] The present invention relates to the technical field of medicine, in particular to a medical product for wound disinfection, more specifically to a wound antibacterial rinse solution for reducing the microbial content of the wound and its preparation method and application, and more specifically The invention relates to a nitrofurazone flushing solution and a preparation method and application thereof. Background technique [0002] (1) Basic situation of nitrofurazone research [0003] 1 Overview [0004] Furacilin Irrigation Solution (Furacilin Irrigation Solution) is generally divided into Furacilin Irrigation Solution and Sterilized Furacilin Irrigation Solution. It is a commonly used clinical preparation in medical institutions and is recorded in "Chinese Hospital Preparation Standards" (Second Edition of Western Medicine Preparations). [0005] As a local antibacterial drug commonly used in clinical practice in hospitals, nitrofurazone solution ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/345A61K47/34A61P17/02A61P31/04
CPCY02A50/30
Inventor 孟慧毛峻琴赵丹王闰邹豪李铁军
Owner 85 HOSPITAL OF PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products